CD8A and neoplasm: Naive T cells bind to co-stimulatory receptors on dendritic cells and differentiate into tumor-specific CD8+ T cells in response to type I interferon (IFN), leading to activation of anti-tumor immune responses and increased immunogenic cell death (Figure 2) [149].